The diagnostic ability of the d-signature to differentiate between CRA and CRC, especially early-stage (stage I–II) and CEA-negative CRC, was of great significance to determine whether the tumor should be resected endoscopically or surgically in clinical practice. This evidence concerns the gene CEACAM5 and neoplasm.